
Novavax, Inc. Share Price
NVAX
$7.77
+$0.36 (4.86%) Last updated on 05 Sep, 2025 | 00:20 ISTNovavax, Inc. Stock Performance
Open $7.38 | Prev. Close $7.41 | Circuit Range N/A |
Day Range $7.24 - $7.78 | Year Range $5.01 - $15.22 | Volume 3,22,277 |
Average Traded $7.56 |
Novavax, Inc. Share Price Chart
$7.77
About Novavax, Inc.
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Novavax, Inc. Historical Data
Day | Open | Close | Change % |
---|---|---|---|
04-Sep-25 | $7.38 | $7.77 | +0.00% |
04-Sep-25 | $7.38 | $7.77 | +5.14% |
03-Sep-25 | $7.54 | $7.39 | -2.12% |
02-Sep-25 | $7.41 | $7.55 | +1.07% |
29-Aug-25 | $7.55 | $7.47 | -1.58% |
28-Aug-25 | $7.71 | $7.59 | +0.00% |
27-Aug-25 | $7.47 | $7.59 | +1.27% |